Sepsis Therapeutics Market to Reach $6.2 Billion by 2028 –

WASHINGTON, Jan. 28, 2022 (Globe Newswire) — A recent analysis by Vantage Market Research of the global sepsis treatments market has found that the rising incidence of sepsis globally is accelerating market growth. The market is primarily driven by increasing research and development programs on immune metabolism, and the global sepsis treatments market is estimated to total USD 6.2 billion by 2028, up from USD 3.5 billion in 2021, with a compound annual growth rate (CAGR) of 7.3%.

Moreover, the increasing number of inventors in the research and development (R&D) sector by governments and key players, to fuel the growth of the global sepsis treatments market, according to market research, Vantage Market Research, in a report titled “Sepsis Therapeutics Market By Drug Class (Aminoglycosides, Cephalosporins, Glycopeptide Antibiotics, Other Drug Classes), By Route Of Administration (Intravenous, Oral), By Region (North America, Latin America, Europe, Asia Pacific) – Global Industry Assessment (2016 – 2021) and Outlook (2022 – 2028)”.

Click here to access a free report form @

(The free sample of this report is readily available upon request).

Our free sample reports include:

  • In-depth industry analysis, introduction, overview, and outbreak of the COVID-19 pandemic.
  • Impact Analysis 170+ Pages Research Report (including the latest research)
  • Provide on-demand class-level guidance 2021 updated regional analysis with graphical representation of trends, scale, and participation, including an updated list of figures and tables.
  • The updated report includes the major market players with their sales volume, business strategy and revenue analysis using Vantage Market Research Methodology.

(Please note that the sample for this report has been updated to include a pre-delivery COVID-19 impact study.)

List of Prominent Players in Sepsis Treatments Market:

  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • GlaxoSmithKline Inc
  • Mylan Nevada
  • Allergan, Inc.

market dynamics:

Global sepsis rate rising to support global sepsis treatment market

Since the past few years, the population around the world has been increasing exponentially. Thus, along with the increase in population, the prevalence of disease also increases. Thus, the number of people suffering from sepsis is increasing which increases the demand for sepsis treatments. According to the World Health Organization (WHO), sepsis kills 11 million people each year, many of them children. Sepsis causes 1 in 5 deaths worldwide. According to a WHO study, nearly half of the 49 million cases of sepsis occur each year among children, resulting in 2.9 million deaths. This can be prevented with early diagnosis and appropriate clinical management. Thus, the demand for sepsis treatments, in turn, is expected to drive market growth over the forecast period.

Increase research and development programs on immune metabolism and increase investments to stimulate market growth

The prevalence of sepsis worldwide is increasing to an unprecedented level. This increases the burden on the research and development (R&D) sector as well as the government. Hence, to address this proliferation; Governments as well as many major players in the market are investing heavily in the research and development sector. Thus, driving market growth during the forecast period. The major players are adopting cooperation strategies in order to identify/develop new drugs to treat sepsis. For example, Asahi Kasei Corporation plans to release ART-123 by 2021 to treat sepsis.

Buy this special report now @

Benefits of Purchasing Sepsis Treatment Market Reports:

  • customers satisfaction: Our expert team helps you with all your research needs and improve your reporting.
  • Analyst Support: Before or after purchasing the report, ask a professional analyst to answer your questions.
  • Guaranteed quality: Focuses on the accuracy and quality of reports.
  • incomparable skills: Analysts provide in-depth insights into reports.

Analysis of the impact of COVID-19:

The COVID-19 outbreak has crippled many sectors. Due to COVID-19, many countries have announced lockdown with strict regulations. As a result, people were stuck in their places. However, the healthcare sector was not affected much, the sepsis treatment market witnessed a negative impact on the market growth. Because of the fear of COVID-19 among the global population, only people with severe sepsis risk visiting hospitals, clinics or other services. Thus, it hampered the growth of the therapeutic market for sepsis. However, things will improve in the second half of 2022 as more supplies will be made available online. The impact of COVID-19 on market demand is considered while estimating the current and projected market size and market growth trends for all regions and countries based on the following data points:

  1. Assessing the impact of the COVID-19 pandemic
    1. North America
    2. Europe
    3. Asia Pacific
    4. Latin america
    5. Middle East and Africa
  2. Quarterly revenue forecasts for the market from Asia Pacific 2020 and 2021
  3. Key strategies companies have taken to tackle COVID-19
  4. long term dynamics
  5. short term dynamics

A report on the Sepsis Treatments Market Report Highlights:

  • Market assessment
  • Distinctive insights
  • Competitive scene
  • Analysis of the impact of COVID
  • Historical data, estimates and forecasts
  • Company Profile
  • Global and Regional Dynamics

Read the full research report @

Regional Analysis:

North America dominates the global market for sepsis treatments

North America dominated the global therapeutic market for sepsis in 2021 and is likely to continue in the same trend during the forecast period. The market growth is owing to the high prevalence and high incidence of sepsis in the United States and Canada. Also, the presence of key players in the region is also expected to support the regional growth of the market.

The Asia Pacific region is likely to experience the fastest growth in the sepsis treatments market during the forecast period. This is attributed to improved healthcare infrastructure in economies such as India and China in the region. Moreover, having one of the most populous countries in the world provides a huge population base that is likely to boost the growth of the sepsis treatment market in the region.

Recent Developments:

August 2021: Asahi Kasei plans to release ART-123 by 2021 to treat sepsis.

August 2019: Entered Pfizer, Inc. In partnership with GlaxoSmithKline plc to form a joint venture to create the world’s largest Over-the-Counter (OTC) company.

Key questions answered in the report:

  • Which regional market will show the highest rapid growth?
  • Who are the top five players in the sepsis treatment market?
  • How will the sepsis treatment market change in the next six years?
  • What application and product will take the lion’s share of the sepsis treatment market?
  • What are the drivers and limitations of the Sepsis Therapeutic Market?
  • What will the CAGR and Sepsis Treatment market size be during the forecast period?

Talk to the analyst:

This market is entitledsepsis treatment market It will cover the exclusive information in terms of regional analysis, forecasting, quantitative data – units, major market trends and various other information as mentioned below:

Report feature details
Market size in 2021 3.5 billion USD
Expected market size in 2028 6.2 billion USD
CAGR growth rate A compound annual growth rate of 7.3% from 2022 to 2028
base year 2021
Historic years 2016 – 2020
prediction years 2022 – 2028
covered slices Drug class: – aminoglycosides, cephalosporins, glycopeptide antibiotics, other drug classes

Method of administration: – intravenously, orally

Quantitative data – units Revenues in US$ Million/Billion and CAGR from 2022 to 2028
Covered areas North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Countries covered United States, Canada, Mexico, United Kingdom, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC countries and South Africa, among others
Report coverage Market growth drivers, restraints, and opportunities, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis, Organizational Landscape, Market Attractiveness Analysis by Segments and Region, Company Market Share Analysis, and COVID-19 Impact Analysis.

Customize the report:

The report can be customized according to the customer’s needs or requirements. For any inquiries, you may contact us at [email protected] or +1 (202) 380-9727. Our sales managers will be happy to understand your needs and provide you with the most appropriate reports.

Download a free report form now @

Browse more related reports:

About Vantage Market Research:

We, at Vantage Market Research, provide high quality, quantitative B2B research for more than 20,000 emerging markets, thus helping our clients identify a range of opportunities for their business. We, as a competitive market intelligence and advisory firm, provide end-to-end solutions to our clients’ organizations to meet their critical business objectives. Our client base spans over 70% of Global Fortune 500 companies. The company provides high quality data and market research reports. The company serves many companies and clients in a variety of industries. The company provides detailed reports on many industries including chemical, energy, food and beverage, healthcare technology, etc. The company’s experienced team of analysts, researchers and consultants uses proprietary data sources and various statistical tools and techniques to collect and analyze information.

Follow us on LinkedIn:

Follow us on Twitter:

call us

Eric Kons

6218 Georgia Avenue NW Ste 1-564

Washington DC 20011-5125

United States Tel: +1202380 9727

email: [email protected]


Latest Market Research Press Releases @ Vantage

The latest market research blog Vantage @


Leave a Comment